- |||||||||| Covovax (NVX-CoV2373) / Novavax, Takeda, Serum Institute of India
Enrollment open: The COVID-19 Back-to-Normal Study (clinicaltrials.gov) - Jun 18, 2021 P=N/A, N=1000, Recruiting, Not yet recruiting --> Recruiting
- |||||||||| BBIBP-CorV / Wuhan Institute of Virology, Sinopharm, Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: no information about the neutralization activity of Ad26.COV2.S (Johnson & Johnson) and Sputnik V (Gamaleya), AZD1222 (AstraZeneca) and BBIBP-CorV (Sinopharm) vaccines against B.1.1.7 and P.1. Variants. (Twitter) - Jun 18, 2021
- |||||||||| Vaxzevria (ChAdOx1-S recombinant) / Oxford Biomedica, Emergent Biosolutions, Jenner Institute, Vaccitech, AstraZeneca, University of Oxford, Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
De las +de 20 mill. que ya se distribuyeron, 9,4 corresponden a Sputnik V (7,8 del componente 1 y 1,5 del 2); 4.000.000, a Sinopharm; 580.000, a AstraZeneca – Covishield; 1.944.000, a AstraZeneca p/Covax y 4.737.400, de @AstraZeneca directo https://t.co/8FlodiMYMo @mgiambar (Twitter) - Jun 18, 2021
- |||||||||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
@Sputnik V kada??? (Twitter) - Jun 13, 2021
- |||||||||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: @sputnikvaccine ? (Twitter) - Jun 11, 2021
|